| 1 | Carcinoma, Ovarian Epithelial | 45.9% |
| 2 | Carcinoma, Endometrioid | 33% |
| 3 | Oophoritis | 23.5% |
| 4 | Parathyroid Neoplasms | 23.2% |
| 5 | Thyroid Neoplasm | 23.2% |
| 6 | Thyroid carcinoma | 23.2% |
| 7 | Corpus Luteum Cyst | 22.2% |
| 8 | Ovarian Cysts | 22.2% |
| 9 | Adrenal Gland Neoplasms | 21.3% |
| 10 | Ovarian Hyperstimulation Syndrome | 20.7% |
| 11 | Multiple Endocrine Neoplasia | 20.3% |
| 12 | Testicular Neoplasms | 18.6% |
| 13 | Anovulation | 18.4% |
| 14 | Pancreatic Neoplasm | 17.9% |
| 15 | Fallopian Tube Neoplasms | 17.3% |
| 16 | Uterine Neoplasms | 17% |
| 17 | Vaginal Neoplasms | 17% |
| 18 | Vulvar Neoplasms | 17% |
| 19 | Uterine Cancer | 17% |
| 20 | Thyroid Nodule | 14.9% |
| 21 | Polycystic Ovary Syndrome | 14.6% |
| 22 | Leydig Cell Tumor | 14.5% |
| 23 | Pituitary Adenoma | 14.5% |
| 24 | Pituitary Neoplasms | 14.5% |
| 25 | Prolactinoma | 13.5% |
| 26 | Growth Hormone-Secreting Pituitary Adenoma | 13.5% |
| 27 | Urologic Neoplasms | 13.2% |
| 28 | Multiple Endocrine Neoplasia Type 1 | 12.7% |
| 29 | Carcinoma, Pancreatic Ductal | 12.5% |
| 30 | Hermaphroditism | 11.7% |
| 31 | Disorders of Sex Development | 11.7% |
| 32 | Salpingitis | 11.4% |
| 33 | Adrenocortical carcinoma | 11.4% |
| 34 | Pregnancy Complications, Neoplastic | 11.2% |
| 35 | Endometrial Neoplasms | 11.2% |
| 36 | Endometritis | 11.1% |
| 37 | Urologic Diseases | 11% |
| 38 | Endometriosis | 10.8% |
| 39 | Uterine Diseases | 10.8% |
| 40 | Vaginal Diseases | 10.8% |
| 41 | Vulvar Diseases | 10.8% |
| 42 | Endometrioma | 10.8% |
| 43 | Endometrial Stromal Sarcoma | 10.6% |
| 44 | Neoplasms, Neuroepithelial | 10.1% |
| 45 | Gliomatosis cerebri | 10.1% |
| 46 | Nephroblastoma | 9.9% |
| 47 | Urogenital Abnormalities | 9.9% |
| 48 | Hypogonadism | 9.8% |
| 49 | Delayed Puberty | 9.8% |
| 50 | Precocious Puberty | 9.8% |
| 51 | Hypogonadotropic hypogonadism | 9.8% |
| 52 | Testotoxicosis | 9.8% |
| 53 | Trophoblastic Neoplasms | 9.8% |
| 54 | Neuroectodermal Tumors | 9.7% |
| 55 | Meningioma | 9.7% |
| 56 | Vipoma | 9.6% |
| 57 | Infertility | 9.5% |
| 58 | Adnexitis | 9.4% |
| 59 | Pelvic Inflammatory Disease | 9.4% |
| 60 | Premature Menopause | 9.4% |
| 61 | insulinoma | 9.4% |
| 62 | Abdominal Neoplasms | 9.3% |
| 63 | Head and Neck Neoplasms | 9.3% |
| 64 | leukemia | 9.3% |
| 65 | Neoplasms, Germ Cell and Embryonal | 9.3% |
| 66 | Neoplasms, Glandular and Epithelial | 9.3% |
| 67 | Soft Tissue Neoplasms | 9.3% |
| 68 | Thoracic Neoplasms | 9.3% |
| 69 | Germ Cell Cancer | 9.3% |
| 70 | Gastrinoma | 9.1% |
| 71 | Glucagonoma | 9.1% |
| 72 | Adrenal Gland Diseases | 9% |
| 73 | Parathyroid Diseases | 9% |
| 74 | Thyroid Diseases | 9% |
| 75 | Bladder Neoplasm | 9% |
| 76 | Kidney Neoplasm | 9% |
| 77 | Ureteral Neoplasms | 9% |
| 78 | Urethral Neoplasms | 9% |
| 79 | Nelson Syndrome | 9% |
| 80 | Mesoblastic Nephroma | 8.7% |
| 81 | Carcinoma 256, Walker | 8.7% |
| 82 | Testicular Diseases | 8.7% |
| 83 | melanoma | 8.6% |
| 84 | Hamartoma | 8.6% |
| 85 | Neoplasms, Hormone-Dependent | 8.6% |
| 86 | Neoplasms, Multiple Primary | 8.6% |
| 87 | Paraneoplastic Syndromes | 8.6% |
| 88 | Precancerous Conditions | 8.6% |
| 89 | Neoplasms, Second Primary | 8.6% |
| 90 | Medulloblastoma | 8.5% |
| 91 | Digestive System Neoplasms | 8.4% |
| 92 | Eye Neoplasms | 8.4% |
| 93 | Nervous System Neoplasms | 8.4% |
| 94 | Carcinoma, Lobular | 8.4% |
| 95 | Bone neoplasms | 8.3% |
| 96 | Skin Neoplasms | 8.3% |
| 97 | Hematologic Neoplasms | 8.3% |
| 98 | Melanoma, Experimental | 8.2% |
| 99 | Histiocytic Disorders, Malignant | 8.2% |
| 100 | Splenic Neoplasms | 8.2% |
| 101 | Carcinosarcoma | 8.1% |
| 102 | Hemangiosarcoma | 8.1% |
| 103 | lymphangiosarcoma | 8.1% |
| 104 | Acanthoma | 8.1% |
| 105 | Paraneoplastic Encephalomyelitis | 8.1% |
| 106 | Leukemia, Experimental | 8% |
| 107 | Mammary Neoplasms, Experimental | 8% |
| 108 | Bone Diseases, Endocrine | 8% |
| 109 | Pregnancy Complications | 8% |
| 110 | Peritoneal Neoplasms | 7.9% |
| 111 | Diabetes Mellitus | 7.9% |
| 112 | Pituitary Diseases | 7.9% |
| 113 | Sexually Transmitted Diseases | 7.8% |
| 114 | Denys-Drash Syndrome | 7.8% |
| 115 | Composite Lymphoma | 7.8% |
| 116 | Genital Herpes | 7.6% |
| 117 | Genital Neoplasms, Female | 7.6% |
| 118 | Cyst | 7.6% |
| 119 | Neoplastic Processes | 7.6% |
| 120 | Neoplastic Syndromes, Hereditary | 7.6% |
| 121 | Neoplasms, Experimental | 7.5% |
| 122 | Kallmann Syndrome | 7.4% |
| 123 | Choriocarcinoma | 7.3% |
| 124 | Carcinoma, Ehrlich Tumor | 7.3% |
| 125 | Dermoid Cyst | 7.3% |
| 126 | Carcinoma, Lewis Lung | 7.3% |
| 127 | Lymphoma | 7.3% |
| 128 | Uterine Inversion | 7.3% |
| 129 | Leukemia, Radiation-Induced | 7.3% |
| 130 | Gestational Diabetes | 7.2% |
| 131 | Thymoma | 7.2% |
| 132 | Leukemia, Plasma Cell | 7.2% |
| 133 | Adenoma, Acidophil | 7.1% |
| 134 | Ganglioneuroma | 7.1% |
| 135 | Glioma | 7.1% |
| 136 | Malignant Glioma | 7.1% |
| 137 | Dwarfism | 7.1% |
| 138 | Renal Cell Carcinoma | 7.1% |
| 139 | Papillary Renal Cell Carcinoma | 7.1% |
| 140 | Retinoblastoma | 7% |
| 141 | Diabetes Insipidus | 7% |
| 142 | Gonadal Dysgenesis | 6.9% |
| 143 | Adrenogenital Syndrome | 6.9% |
| 144 | Ovotesticular Disorders of Sex Development | 6.9% |
| 145 | Klinefelter Syndrome | 6.7% |
| 146 | Bladder Exstrophy | 6.7% |
| 147 | Epispadias | 6.7% |
| 148 | Neoplasms, Radiation-Induced | 6.7% |
| 149 | Tuberculosis, Renal | 6.7% |
| 150 | Tuberous Sclerosis | 6.7% |
| 151 | Vulvovaginitis | 6.6% |
| 152 | Tracheal Neoplasms | 6.6% |
| 153 | Parametritis | 6.5% |
| 154 | Uterine Rupture | 6.5% |
| 155 | Hyperandrogenism | 6.5% |
| 156 | Sarcoma, Experimental | 6.5% |
| 157 | Basal cell carcinoma | 6.4% |
| 158 | Carcinoma, Papillary | 6.4% |
| 159 | Squamous cell carcinoma | 6.4% |
| 160 | Chondrosarcoma | 6.4% |
| 161 | Craniopharyngioma | 6.4% |
| 162 | Cystadenoma | 6.4% |
| 163 | leiomyosarcoma | 6.4% |
| 164 | liposarcoma | 6.4% |
| 165 | Mesothelioma | 6.4% |
| 166 | synovial sarcoma | 6.4% |
| 167 | Neuroectodermal Tumor, Melanotic | 6.4% |
| 168 | Angiomyolipoma | 6.4% |
| 169 | Clear Cell Sarcoma of Soft Tissue | 6.4% |
| 170 | Alveolar Soft Part Sarcoma | 6.4% |
| 171 | Neuroendocrine Tumors | 6.4% |
| 172 | Sarcoma, Myeloid | 6.4% |
| 173 | Carcinoma, Basal Cell | 6.4% |
| 174 | Carcinoid Tumor | 6.4% |
| 175 | Neurilemmoma | 6.4% |
| 176 | Hutchinson's Melanotic Freckle | 6.4% |
| 177 | Melanoma, Amelanotic | 6.4% |
| 178 | Acoustic Neuroma | 6.3% |
| 179 | Endometrial Hyperplasia | 6.1% |
| 180 | Pyometra | 6.1% |
| 181 | Vaginitis | 6.1% |
| 182 | Vulvitis | 6.1% |
| 183 | Vaginal Discharge | 6.1% |
| 184 | Vulvodynia | 6.1% |
| 185 | Esophageal Neoplasms | 5.9% |
| 186 | Endocrine Gland Neoplasms | 5.9% |
| 187 | Urinary Bladder Diseases | 5.8% |
| 188 | Kidney Diseases | 5.8% |
| 189 | Ureteral Diseases | 5.8% |
| 190 | Urethral Diseases | 5.8% |
| 191 | Urination Disorders | 5.8% |
| 192 | Urolithiasis | 5.8% |
| 193 | Multicystic Dysplastic Kidney | 5.8% |
| 194 | Astrocytoma | 5.7% |
| 195 | Ependymoma | 5.7% |
| 196 | oligodendroglioma | 5.7% |
| 197 | Ganglioglioma | 5.7% |
| 198 | gliosarcoma | 5.7% |
| 199 | Anaplastic astrocytoma | 5.7% |
| 200 | Anaplastic Oligodendroglioma | 5.7% |
| 201 | Leukemia L1210 | 5.7% |
| 202 | Leukemia P388 | 5.7% |
| 203 | Cystadenocarcinoma | 5.6% |
| 204 | Fibrosarcoma | 5.6% |
| 205 | Osteosarcoma | 5.6% |
| 206 | Mucoepidermoid Carcinoma | 5.6% |
| 207 | ovarian neoplasm | 5.6% |
| 208 | Adenoma | 5.5% |
| 209 | Ameloblastoma | 5.5% |
| 210 | Angiokeratoma | 5.5% |
| 211 | Carcinoma | 5.5% |
| 212 | Chordoma | 5.5% |
| 213 | Hemangioma | 5.5% |
| 214 | hemangiopericytoma | 5.5% |
| 215 | Lymphangioma | 5.5% |
| 216 | Mesenchymoma | 5.5% |
| 217 | Nevus | 5.5% |
| 218 | Retroperitoneal Neoplasms | 5.5% |
| 219 | Teratoma | 5.5% |
| 220 | Hepatoblastoma | 5.5% |
| 221 | Mixed Tumor, Mullerian | 5.5% |
| 222 | Germinoma | 5.5% |
| 223 | Teratocarcinoma | 5.5% |
| 224 | Angiofibroma | 5.5% |
| 225 | Sarcoma | 5.5% |
| 226 | Epithelioma | 5.5% |
| 227 | Diabetic Nephropathy | 5.5% |
| 228 | Vesicovaginal Fistula | 5.5% |
| 229 | Basal Cell Nevus Syndrome | 5.4% |
| 230 | Optic Nerve Glioma | 5.4% |
| 231 | Congenital Hypothyroidism | 5.4% |
| 232 | Pruritus Vulvae | 5.4% |
| 233 | Uterine hemorrhage | 5.4% |
| 234 | Vaginal Fistula | 5.4% |
| 235 | Liver Neoplasms, Experimental | 5.4% |
| 236 | Anuria | 5.4% |
| 237 | Ureterolithiasis | 5.4% |
| 238 | Nephrolithiasis | 5.4% |
| 239 | Uterine Prolapse | 5.3% |
| 240 | Vaginal Prolapse | 5.3% |
| 241 | Malignant Carcinoid Syndrome | 5.3% |
| 242 | Orchitis | 5.3% |
| 243 | Urinary tract infection | 5.2% |
| 244 | Adenofibroma | 5.2% |
| 245 | Fibroadenoma | 5.2% |
| 246 | Malignant Fibrous Histiocytoma | 5.2% |
| 247 | Horseshoe Kidney | 5.2% |
| 248 | Hepatocellular Adenoma | 5.2% |
| 249 | Lymphomatoid Granulomatosis | 5.2% |
| 250 | Lymphangioleiomyomatosis | 5.2% |
| 251 | Adrenal Cortex Diseases | 5.1% |
| 252 | Euthyroid Sick Syndromes | 5.1% |
| 253 | Goiter | 5.1% |
| 254 | Hyperparathyroidism | 5.1% |
| 255 | Hyperthyroidism | 5.1% |
| 256 | Hyperthyroxinemia | 5.1% |
| 257 | Hypoparathyroidism | 5.1% |
| 258 | Hypothyroidism | 5.1% |
| 259 | Thyroiditis | 5.1% |
| 260 | Secondary hypothyroidism | 5.1% |
| 261 | Primary Hyperthyroidism | 5.1% |
| 262 | Primary Hypothyroidism | 5.1% |
| 263 | Glioblastoma | 5% |
| 264 | Neuroblastoma | 5% |
| 265 | Glioblastoma Multiforme | 5% |
| 266 | Neurofibrosarcoma | 4.9% |
| 267 | Mouth Neoplasms | 4.9% |
| 268 | Central Nervous System Neoplasms | 4.9% |
| 269 | Vascular Neoplasms | 4.9% |
| 270 | Thymus Neoplasms | 4.9% |
| 271 | Plasmacytoma | 4.9% |
| 272 | Urinary Bladder Fistula | 4.9% |
| 273 | Malignant histiocytosis | 4.9% |
| 274 | Breast Neoplasms, Male | 4.9% |
| 275 | Histiocytic sarcoma | 4.9% |
| 276 | Triple Negative Breast Neoplasms | 4.9% |
| 277 | Sarcoma 180 | 4.8% |
| 278 | Turner Syndrome | 4.8% |
| 279 | Bowen's Disease | 4.8% |
| 280 | Paraganglioma | 4.8% |
| 281 | Rhabdomyosarcoma | 4.8% |
| 282 | Giant Cell Tumor of Bone | 4.8% |
| 283 | Dyspareunia | 4.8% |
| 284 | Gonadal Disorders | 4.8% |
| 285 | Hypospadias | 4.7% |
| 286 | Erythroplasia | 4.7% |
| 287 | Follicular cyst | 4.7% |
| 288 | Mucocele | 4.7% |
| 289 | Pilonidal Cyst | 4.7% |
| 290 | Thyroglossal Cyst | 4.7% |
| 291 | Synovial Cyst | 4.7% |
| 292 | Aberrant Crypt Foci | 4.7% |
| 293 | Ganglioneuroblastoma | 4.6% |
| 294 | Graves Disease | 4.6% |
| 295 | Leukoplakia, Oral | 4.6% |
| 296 | Paraneoplastic Cerebellar Degeneration | 4.5% |
| 297 | Adenomatous Polyposis Coli | 4.5% |
| 298 | Empty Sella Syndrome | 4.5% |
| 299 | Hyperpituitarism | 4.5% |
| 300 | Hypopituitarism | 4.5% |
| 301 | Hypophysitis | 4.5% |
| 302 | Uterine Cervical Incompetence | 4.4% |
| 303 | Dermatofibrosarcoma | 4.4% |
| 304 | Dermatofibrosarcoma Protuberans | 4.4% |
| 305 | Gastrointestinal Neoplasms | 4.4% |
| 306 | Genital Neoplasms, Male | 4.4% |
| 307 | Liver neoplasms | 4.4% |
| 308 | Uveal Neoplasms | 4.4% |
| 309 | Bladder neck obstruction | 4.4% |
| 310 | Carcinoid Heart Disease | 4.4% |
| 311 | Sebaceous Gland Neoplasms | 4.3% |
| 312 | Spinal Neoplasms | 4.3% |
| 313 | Bone Marrow Neoplasms | 4.3% |
| 314 | Hodgkin Disease | 4.3% |
| 315 | Lymphoma, Non-Hodgkin | 4.3% |
| 316 | Ovarian Diseases | 4.3% |
| 317 | Cryptorchidism | 4.3% |
| 318 | Hydatidiform Mole | 4.2% |
| 319 | Leukoplakia | 4.1% |
| 320 | Lymphocele | 4.1% |
| 321 | Pancreatic Cyst | 4.1% |
| 322 | Limbic Encephalitis | 4.1% |
| 323 | Candidiasis, Vulvovaginal | 4.1% |
| 324 | Barrett Esophagus | 4.1% |
| 325 | Breast Cyst | 4.1% |
| 326 | Actinic keratosis | 4.1% |
| 327 | Mediastinal Cyst | 4.1% |
| 328 | Neoplasm Invasiveness | 4.1% |
| 329 | Neoplasm Metastasis | 4.1% |
| 330 | Neoplasm Recurrence, Local | 4.1% |
| 331 | Parovarian Cyst | 4.1% |
| 332 | Pericardial Cyst | 4.1% |
| 333 | Thymic Cyst | 4.1% |
| 334 | Carcinogenesis | 4.1% |
| 335 | Myxoid cyst | 4.1% |
| 336 | Metastasis | 4.1% |
| 337 | Nose Neoplasms | 4.1% |
| 338 | Polyhydramnios | 4.1% |
| 339 | Obstetric Labor Complications | 4.1% |
| 340 | Ectopic Pregnancy | 4.1% |
| 341 | Pregnancy, Prolonged | 4.1% |
| 342 | Puerperal Disorders | 4.1% |
| 343 | Oligohydramnios | 4.1% |
| 344 | Prenatal Injuries | 4.1% |
| 345 | Latent Autoimmune Diabetes in Adults | 4% |
| 346 | Chorioamnionitis | 4% |
| 347 | Pheochromocytoma | 4% |
| 348 | Alveolar rhabdomyosarcoma | 4% |
| 349 | Diabetes Mellitus, Experimental | 4% |
| 350 | Primary amyloidosis | 3.9% |
| 351 | granulosa cell tumor | 3.9% |
| 352 | Kidney Calculi | 3.9% |
| 353 | Ureteral Calculi | 3.9% |
| 354 | Abruptio Placentae | 3.9% |
| 355 | Placenta Accreta | 3.9% |
| 356 | Lambert-Eaton Myasthenic Syndrome | 3.8% |
| 357 | Uterine Cervicitis | 3.8% |
| 358 | Leukorrhea | 3.8% |
| 359 | Palatal Neoplasms | 3.8% |
| 360 | Adenocarcinoma | 3.7% |
| 361 | Carcinoma in Situ | 3.7% |
| 362 | Carcinoma, Transitional Cell | 3.7% |
| 363 | Phyllodes Tumor | 3.7% |
| 364 | Dysgerminoma | 3.7% |
| 365 | Hemangioendothelioma | 3.7% |
| 366 | Lipoma | 3.7% |
| 367 | Myoma | 3.7% |
| 368 | Myxoma | 3.7% |
| 369 | Neuroma | 3.7% |
| 370 | Papilloma | 3.7% |
| 371 | Pseudomyxoma Peritonei | 3.7% |
| 372 | Seminoma | 3.7% |
| 373 | Papillomatosis | 3.7% |
| 374 | Angiolipoma | 3.7% |
| 375 | Myelolipoma | 3.7% |
| 376 | Neoplasms, Bone Tissue | 3.7% |
| 377 | Neoplasms, Fibrous Tissue | 3.7% |
| 378 | Smooth Muscle Tumor | 3.7% |
| 379 | Adenomatosis, Pulmonary | 3.7% |
| 380 | Adenomatous Polyps | 3.7% |
| 381 | Carcinoma, Large Cell | 3.7% |
| 382 | Carcinoma, Small Cell | 3.7% |
| 383 | Desmoplastic Small Round Cell Tumor | 3.7% |
| 384 | Chondroma | 3.7% |
| 385 | Enchondroma | 3.7% |
| 386 | Fetal Diseases | 3.7% |
| 387 | Pregnancy Complications, Cardiovascular | 3.7% |
| 388 | Pregnancy Complications, Hematologic | 3.6% |
| 389 | Pregnancy Complications, Infectious | 3.6% |
| 390 | Fetal Death | 3.6% |
| 391 | Perinatal death | 3.6% |
| 392 | Pituitary Apoplexy | 3.6% |
| 393 | Morning Sickness | 3.6% |
| 394 | Opsoclonus-Myoclonus Syndrome | 3.5% |
| 395 | Puerperal Infection | 3.4% |
| 396 | Postpartum Hemorrhage | 3.4% |
| 397 | Bacterial Vaginosis | 3.4% |
| 398 | Cystitis | 3.3% |
| 399 | Hydronephrosis | 3.3% |
| 400 | Hyperoxaluria | 3.3% |
| 401 | Kidney Cortex Necrosis | 3.3% |
| 402 | Kidney Papillary Necrosis | 3.3% |
| 403 | Nephritis | 3.3% |
| 404 | Nephrosclerosis | 3.3% |
| 405 | Nephrosis | 3.3% |
| 406 | Perinephritis | 3.3% |
| 407 | Kidney Failure | 3.3% |
| 408 | Uremia | 3.3% |
| 409 | Ureteral obstruction | 3.3% |
| 410 | Ureterocele | 3.3% |
| 411 | Urethral Obstruction | 3.3% |
| 412 | Urethritis | 3.3% |
| 413 | Vesico-Ureteral Reflux | 3.3% |
| 414 | Urinary Retention | 3.3% |
| 415 | Oxalosis | 3.3% |
| 416 | Renal Insufficiency | 3.3% |
| 417 | Trichomonas Vaginitis | 3.3% |
| 418 | Uterine Perforation | 3.3% |
| 419 | Metrorrhagia | 3.3% |
| 420 | Choledochal Cyst | 3.3% |
| 421 | Renal Osteodystrophy | 3.3% |
| 422 | Renal rickets | 3.3% |
| 423 | Waldenstrom Macroglobulinemia | 3.3% |
| 424 | Multiple Myeloma | 3.3% |
| 425 | Peutz-Jeghers Syndrome | 3.3% |
| 426 | Myelitis, Transverse | 3.3% |
| 427 | Cushing Syndrome | 3.2% |
| 428 | Hyperaldosteronism | 3.2% |
| 429 | Hyperparathyroidism, Secondary | 3.2% |
| 430 | Hypoaldosteronism | 3.2% |
| 431 | Thyrotoxicosis | 3.2% |
| 432 | Hyperparathyroidism, Primary | 3.2% |
| 433 | Thyroid Hormone Resistance Syndrome | 3.2% |
| 434 | Meningeal Neoplasms | 3.2% |
| 435 | Diabetic Foot | 3.2% |
| 436 | Leukemia, Myelomonocytic, Chronic | 3.2% |
| 437 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.2% |
| 438 | Nasopharyngeal carcinoma | 3.2% |
| 439 | Hepatorenal Syndrome | 3% |
| 440 | Bacteriuria | 3% |
| 441 | Glycosuria | 3% |
| 442 | Hematuria | 3% |
| 443 | Renal hypertension | 3% |
| 444 | Oliguria | 3% |
| 445 | Polyuria | 3% |
| 446 | Proteinuria | 3% |
| 447 | Pyuria | 3% |
| 448 | Renal Artery Obstruction | 3% |
| 449 | Renal Artery Stenosis | 3% |
| 450 | Urinary Calculi | 3% |
| 451 | Cystocele | 3% |
| 452 | Nephrocalcinosis | 3% |
| 453 | Urinary Incontinence | 3% |
| 454 | Menorrhagia | 3% |
| 455 | Ear Neoplasms | 2.9% |
| 456 | Eyelid Neoplasms | 2.9% |
| 457 | Lung Neoplasms | 2.9% |
| 458 | Pleural Neoplasms | 2.9% |
| 459 | Mastocytosis | 2.9% |
| 460 | Sturge-Weber Syndrome | 2.9% |
| 461 | Brain Neoplasms | 2.9% |
| 462 | Salivary Gland Neoplasms | 2.9% |
| 463 | Spinal Cord Neoplasms | 2.9% |
| 464 | Tongue Neoplasms | 2.9% |
| 465 | Gastrointestinal Stromal Tumors | 2.9% |
| 466 | Pyelocystitis | 2.9% |
| 467 | Hemangioma, Cavernous | 2.9% |
| 468 | Addison Disease | 2.9% |
| 469 | Diabetic Angiopathies | 2.9% |
| 470 | Autoimmune thyroiditis | 2.9% |
| 471 | Primary Adrenal Insufficiency | 2.9% |
| 472 | Leukemia, T-Cell | 2.9% |
| 473 | Leukemia, B-Cell | 2.9% |
| 474 | neurofibroma | 2.9% |
| 475 | Lymphoma, Follicular | 2.9% |
| 476 | T-Cell Lymphoma | 2.9% |
| 477 | Mantle cell lymphoma | 2.9% |
| 478 | Diabetic Neuropathies | 2.8% |
| 479 | Myxedema | 2.8% |
| 480 | Diabetic Amyotrophy | 2.8% |
| 481 | Diabetic Autonomic Neuropathy | 2.8% |
| 482 | Diabetic Cardiomyopathies | 2.8% |
| 483 | Hyperprolactinemia | 2.8% |
| 484 | Adenoid Cystic Carcinoma | 2.8% |
| 485 | fibroma | 2.8% |
| 486 | Fibromatosis | 2.8% |
| 487 | Osteoblastoma | 2.8% |
| 488 | Osteoma | 2.8% |
| 489 | Rhabdomyoma | 2.8% |
| 490 | Chondromatosis | 2.8% |
| 491 | Adenocarcinoma, Clear Cell | 2.8% |
| 492 | Cholangiocarcinoma | 2.8% |
| 493 | Cervical Intraepithelial Neoplasia | 2.8% |
| 494 | Hemangioblastoma | 2.8% |
| 495 | Lymphoma, Extranodal NK-T-Cell | 2.8% |
| 496 | Enuresis | 2.7% |
| 497 | Pharyngeal Neoplasms | 2.7% |
| 498 | Central Nervous System Cysts | 2.6% |
| 499 | Bile Duct Neoplasms | 2.6% |
| 500 | gallbladder neoplasm | 2.6% |
| 501 | Intestinal Neoplasms | 2.6% |
| 502 | Penile Neoplasms | 2.6% |
| 503 | Prostatic Neoplasms | 2.6% |
| 504 | Stomach Neoplasms | 2.6% |
| 505 | Glycosuria, Renal | 2.6% |
| 506 | Polycythemia Vera | 2.6% |
| 507 | Gigantism | 2.5% |
| 508 | Acromegaly | 2.5% |
| 509 | Diabetic Ketoacidosis | 2.5% |
| 510 | Pancreatic Pseudocyst | 2.4% |
| 511 | Laryngeal neoplasm | 2.4% |
| 512 | AIDS-Associated Nephropathy | 2.4% |
| 513 | Lymphatic Metastasis | 2.4% |
| 514 | Neoplasms, Unknown Primary | 2.4% |
| 515 | Leukemic Infiltration | 2.4% |
| 516 | Neoplasm Micrometastasis | 2.4% |
| 517 | Mastocytoma | 2.4% |
| 518 | Chlamydia Infections | 2.4% |
| 519 | Gonorrhea | 2.4% |
| 520 | Meningeal Carcinomatosis | 2.4% |
| 521 | Mastocytosis, Systemic | 2.4% |
| 522 | Leukemia, Myeloid, Chronic-Phase | 2.4% |
| 523 | Pyelonephritis | 2.4% |
| 524 | Xeroderma Pigmentosum | 2.4% |
| 525 | Hyperglycemic Hyperosmolar Nonketotic Coma | 2.3% |
| 526 | Hashimoto Disease | 2.3% |
| 527 | Fibromatosis, Aggressive | 2.3% |
| 528 | Fibromatosis, Abdominal | 2.3% |
| 529 | Klatskin Tumor | 2.3% |
| 530 | Syphilis | 2.2% |
| 531 | Abortion, Habitual | 2.2% |
| 532 | Dystocia | 2.2% |
| 533 | Eclampsia | 2.2% |
| 534 | Fetal Membranes, Premature Rupture | 2.2% |
| 535 | Placental Insufficiency | 2.2% |
| 536 | Pre-Eclampsia | 2.2% |
| 537 | Prenatal Exposure Delayed Effects | 2.2% |
| 538 | HELLP Syndrome | 2.2% |
| 539 | Placenta, Retained | 2.2% |
| 540 | Bronchial Neoplasms | 2.2% |
| 541 | Multiple Pulmonary Nodules | 2.2% |
| 542 | Supratentorial Neoplasms | 2.1% |
| 543 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 544 | Leukemia, Large Granular Lymphocytic | 2.1% |
| 545 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 546 | Lymphoma, T-Cell, Cutaneous | 2.1% |
| 547 | Lymphoma, AIDS-Related | 2.1% |
| 548 | Enteropathy-Associated T-Cell Lymphoma | 2.1% |
| 549 | Primary Effusion Lymphoma | 2.1% |
| 550 | Glomerulonephritis | 2.1% |
| 551 | Nephritis, Interstitial | 2.1% |
| 552 | Lipoid nephrosis | 2.1% |
| 553 | Nephrotic Syndrome | 2.1% |
| 554 | Pyelitis | 2.1% |
| 555 | Pyonephrosis | 2.1% |
| 556 | Urethral Stenosis | 2.1% |
| 557 | Nephrogenic Diabetes Insipidus | 2.1% |
| 558 | Congenital Nephrogenic Diabetes Insipidus | 2.1% |
| 559 | Acute kidney injury | 2.1% |
| 560 | Urethral stricture | 2.1% |
| 561 | Abortion, Veterinary | 2% |
| 562 | Pregnancy Complications, Parasitic | 2% |
| 563 | Hypopharyngeal Neoplasms | 1.9% |
| 564 | Pleural Effusion, Malignant | 1.9% |
| 565 | Hypopharyngeal Cancer | 1.9% |
| 566 | Parotid Neoplasms | 1.9% |
| 567 | Prostatic Neoplasms, Castration-Resistant | 1.9% |
| 568 | Lactation Disorder | 1.9% |
| 569 | Mastitis | 1.9% |
| 570 | Depression, Postpartum | 1.9% |
| 571 | Embryo Loss | 1.9% |
| 572 | Fetal Resorption | 1.9% |
| 573 | Hyperemesis Gravidarum | 1.9% |
| 574 | Azotemia | 1.9% |
| 575 | Albuminuria | 1.9% |
| 576 | Hemoglobinuria | 1.9% |
| 577 | Hypertension, Renovascular | 1.9% |
| 578 | Urge Incontinence | 1.9% |
| 579 | Diabetic Retinopathy | 1.8% |
| 580 | Dupuytren Contracture | 1.8% |
| 581 | Urticaria Pigmentosa | 1.8% |
| 582 | Brain Stem Neoplasms | 1.8% |
| 583 | Mycosis Fungoides | 1.8% |
| 584 | Lymphomatoid Papulosis | 1.8% |
| 585 | Plasmablastic lymphoma | 1.8% |
| 586 | Cecal Neoplasms | 1.8% |
| 587 | Duodenal Neoplasms | 1.8% |
| 588 | Burkitt Lymphoma | 1.8% |
| 589 | Fetal Growth Retardation | 1.7% |
| 590 | Embolism, Amniotic Fluid | 1.7% |
| 591 | Fetal Hypoxia | 1.7% |
| 592 | Fetal Alcohol Spectrum Disorders | 1.7% |
| 593 | Breech Presentation | 1.7% |
| 594 | Stillbirth | 1.7% |
| 595 | Polycystic Kidney Diseases | 1.7% |
| 596 | Diurnal Enuresis | 1.7% |
| 597 | Renal Aminoacidurias | 1.7% |
| 598 | Fanconi Syndrome | 1.7% |
| 599 | Pseudohypoaldosteronism | 1.7% |
| 600 | Liddle Syndrome | 1.7% |
| 601 | Hemolytic-Uremic Syndrome | 1.7% |
| 602 | Zellweger Syndrome | 1.7% |
| 603 | Lymphogranuloma Venereum | 1.7% |
| 604 | Nasopharyngeal Neoplasms | 1.6% |
| 605 | Colorectal Neoplasms | 1.6% |
| 606 | Tonsillar Neoplasms | 1.6% |
| 607 | Cerebellar Neoplasms | 1.6% |
| 608 | Choroid Plexus Papilloma | 1.6% |
| 609 | Renal tubular acidosis | 1.5% |
| 610 | Paranasal Sinus Neoplasms | 1.5% |
| 611 | Zollinger-Ellison syndrome | 1.5% |
| 612 | Balkan Nephropathy | 1.5% |
| 613 | Focal glomerulosclerosis | 1.5% |
| 614 | Kidney Failure, Chronic | 1.5% |
| 615 | Waterhouse-Friderichsen Syndrome | 1.5% |
| 616 | Sezary Syndrome | 1.5% |
| 617 | Appendiceal Neoplasms | 1.5% |
| 618 | Colonic Neoplasms | 1.5% |
| 619 | Rectal Neoplasms | 1.5% |
| 620 | Cell Transformation, Viral | 1.4% |
| 621 | Meconium Aspiration Syndrome | 1.4% |
| 622 | Glomerulonephritis, Membranoproliferative | 1.4% |
| 623 | Hyperphosphaturia | 1.3% |
| 624 | Premature Birth | 1.3% |
| 625 | Maxillary Sinus Neoplasms | 1.2% |
| 626 | Anti-Glomerular Basement Membrane Disease | 1.2% |
| 627 | Lupus Nephritis | 1.2% |
| 628 | Polycystic Kidney, Autosomal Dominant | 1.2% |
| 629 | Cystinuria | 1.2% |
| 630 | Atypical Hemolytic Uremic Syndrome | 1.2% |
| 631 | Anus Neoplasms | 1.2% |
| 632 | Sigmoid Neoplasms | 1.2% |
| 633 | Galactorrhea | 1.1% |
| 634 | Adrenoleukodystrophy | 1% |
| 635 | Radicular Cyst | 0.7% |
| 636 | Hydrops Fetalis | 0.7% |
| 637 | Familial Hypophosphatemic Rickets | 0.7% |